Omv AG OMV ORD SHS/ AT0000743059 /
2024-05-30 9:00:00 PM | Chg. - | Volume | Bid11:42:01 AM | Ask11:42:01 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
45.55EUR | - | 89,200 Turnover: 4.09 mill. |
40.22Bid Size: 1,500 | 41.92Ask Size: 1,500 | 13.42 bill.EUR | 12.31% | 9.06 |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
2021-07-28
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
euro adhoc
2021-06-07
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
2021-06-07
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center